ExploreOutcomePatient misconceptions about insulin safety
Outcome

Patient misconceptions about insulin safety

Also known as: Patient misconceptions about insulin safety and disease stage signaling
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (27)

None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un
None
adverse

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

Size: 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/un

Papers (1)